Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02929160Not ApplicableWithdrawn

Percutaneous Nephrostomy Versus Stent In Sepsis Trial

Role: lead

NCT02893228Phase 4Completed

Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block?

Role: lead

NCT03551860Not ApplicableUnknown

Quadratus Lumborum Block Versus Fascia Iliaca Nerve Block for Patients Undergoing Total Hip Replacement

Role: lead

NCT03296189Not ApplicableUnknown

Local Anaesthetic and Steroid in the Ureter

Role: lead

NCT03306238Not ApplicableUnknown

LAParoscopic Entry Technique in REnal Surgery

Role: lead

NCT03282487Phase 4Unknown

Optimising Steroid Replacement in Patients With Adrenal Insufficiency

Role: lead

All 6 trials loaded